Head-to-head · Value Score
bmiMD vs Trimrose
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Trimrose a 50. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#11 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameTrimrose
#384 · Grade C · Watch List
Est. first month
From $269/mo (compounded)
Save ~80% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 50 — an est. $99/mo first month, with no teaser step-up baked in. Trimrose isn't out of it: Shoppers who want a fully online compounded GLP-1 quiz-to-door funnel with weekly injection or daily oral options.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | Trimrose |
|---|---|---|
| Value Score | 89 (A) | 50 (C) |
| Est. first month | $99/mo | From $269/mo (compounded) |
| Save vs brand-name | ~93% | ~80% |
| Semaglutide | $99/mo | Not disclosed |
| Tirzepatide | $139/mo | Not disclosed |
| Both molecules | Yes | No |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
Trimrose
Trimrose (Trimrose Inc.) is a cash-pay telehealth platform for compounded GLP-1 weight loss, offered as a weekly injection or a daily oral option.
Why it's a deal
- Free, no-cost, no-obligation online eligibility quiz before any commitment
- Offers a choice of a weekly compounded GLP-1 injection or a daily oral option
- Fully online — assessment, provider review, and home delivery with ongoing support
The fine print
- Runs on the CareValidate white-label platform and isn't the medical provider itself — a support@carevalidate.com address is exposed on the site
- Pricing isn't shown publicly; the cost and the specific compounded molecule appear only after you complete the eligibility quiz
- The states served, pharmacy partner and any LegitScript/503A certification aren't disclosed on the public site
- Markets 'up to 22.5% of body weight' — a trial figure for branded tirzepatide, not a guaranteed or compounded-specific outcome
- Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to Trimrose.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.